HUNTINGTON NATIONAL BANK - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 1 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$010.0%0.00%
Q2 2023$010.0%0.00%
Q1 2023$010.0%0.00%
Q4 2022$010.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$0
-100.0%
1
-100.0%
0.00%
-100.0%
Q1 2016$29,000
+70.6%
3,689
+9.8%
0.00%
Q2 2015$17,000
-41.4%
3,360
-8.9%
0.00%
-100.0%
Q1 2015$29,000
+31.8%
3,6890.0%0.00%0.0%
Q4 2014$22,0003,689
+570.7%
0.00%
Q2 2011$0
-100.0%
5500.0%0.00%
Q1 2011$2,000
-50.0%
5500.0%0.00%
Q4 2010$4,0005500.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 3,000,000$5,160,0004.58%
Foresite Capital Management II, LLC 6,225,049$10,707,0003.59%
Scale Management, LLC 1,312,575$2,258,0003.46%
NEA Management Company, LLC 3,709,000$6,379,0000.41%
Cheyne Capital Management (UK) LLP 413,200$709,0000.38%
Rhenman & Partners Asset Management AB 1,189,000$2,045,0000.31%
SAMLYN CAPITAL, LLC 6,160,417$10,596,0000.22%
Rock Springs Capital Management LP 1,650,000$2,838,0000.22%
Palo Alto Investors LP 1,673,024$2,878,0000.16%
GLOBEFLEX CAPITAL L P 295,000$507,0000.14%
View complete list of OREXIGEN THERAPEUTICS INC shareholders